December 12, 2025 article Open access Human in vitro neuromuscular junction model to functionally dissect the pathogenic mechanism of anti-AChR autoantibody-positive myasthenia gravis BMC Pharmacology and Toxicology DOI: 10.1186/s40360-025-01056-1 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 1 References 2 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial 2021 The Lancet Neurology article Medicine Myasthenia Gravis and Thymoma Open access cited by 7 patents 733 citations A bioassay for neuromuscular junction-restricted complement activation by myasthenia gravis acetylcholine receptor antibodies 2022 Journal of Neuroscience Methods article Medicine Myasthenia Gravis and Thymoma Open access 17 citations 2 results